For Biotech investors
Catch Trial Shifts Before
the Market Moves
Spot changes first, adjust strategy early, protect downside, and capture upside before headlines hit.
Gain Conviction, Cut Risk.
Make higher-conviction bets.
Track novel targets in early development and capture asymmetric upside before consensus moves.
Move weeks ahead of the Street.
Anticipate catalysts by flagging red signals across your coverage — giving you a 2–3 week head start.
Cut research time by 80%.
Stop pulling trial updates one by one. Monitor your full portfolio’s clinical risk in a single dashboard.
Dump losers before they blow up.
Protect your P&L, see failure signals weeks before consensus and sidestep 30% biotech drawdowns.
The risk was in the data, but you didn’t see it.
Catch trial disruptions early and adjust positions before the market reacts.
